Jul 2026· Annals of Pathology and Laboratory Medicine· Vol 13, pp. A341-A348· 0 citations
TL;DR
The increasing proportion of multiple primary malignancies should raise the suspicion of second primaries while evaluating and following up patients with malignancies, so that a curative treatment can be offered.
Abstract
Background Multiple primary malignancies (MPM) are the subsequent malignancies occurring in an individual with an already diagnosed malignancy. This study was conducted to determine the proportion, clinicopathological characteristics, treatment intent and overall survival of MPMs detected in patients at a tertiary care cancer centre in North Kerala, India.
Materials & Methods The case records of 11250 patients who presented to our institution between January 2021 and December 2022 were retrospectively evaluated for the presence of MPMs. The MPMs were defined by the IARC/IACR criteria. The patient details were recorded from archives. Descriptive statistics were used for categorical variables. The patients were followed up for a minimum period of 2 years and overall survival was calculated.
Results Out of the 11250 patients who presented to our institution between January 2021 and December 2022, 121 patients had MPMs (1.08%). 115 (95%) patients were found to have double primary malignancies. Triple primary malignancies were identified in 6 (5%) patients. 38 patients were found to have SyPMs (33%) and 77 with McPMs (67%). Breast was the most common index primary malignancy (41; 35.6%) followed by colon (15; 13%) and gynecologic malignancies (14; 12.2%). The patients with McPM had better overall survival than SyPMs.
Conclusion The increasing proportion of multiple primary malignancies should raise the suspicion of second primaries while evaluating and following up patients with malignancies. Efforts must be made to diagnose the second primaries in the earlier stage so that a curative treatment can be offered.
The key to improving outcomes in this growing subset of oncology patients lies in early identification by vigilant follow-up, appropriate screening, and management strategies tailored to the individual patient.
S. Swain, Lalatendu Moharana, Sudam Sadangi et al.· South Asian Journal of Cance...· 0 citations
The incidence of MpBC is consistent with literature, and most patients have early disease progression and poor prognosis in comparison to other breast cancer subtypes, where the current protocols are still under evaluation.
Sadia Siddiky, Sarder Rizwan Nayeem, Neil Mclean et al.· The Surgeon· 1 citation
Background: Cancer is an expanding cause of morbidity and mortality worldwide, with a growing share of the burden occurring in low- and middle-income countries. In sub-Saharan Africa, deficiencies in population-based registration, pathology, imaging, screening, and treatment access continue to limit cancer control. Hos...
Otache Adah Emmanuel, Agida E. Teddy, R. Abah et al.· SAR Journal of Medicine· 0 citations
Female patients predominated slightly, and the incidence of gastric and esophageal cancers was significantly higher than reported in the literature, suggesting that regional environmental, dietary, and sociocultural factors play a critical role in shaping cancer distribution across the Eastern Anatolia region.
Ismet Kızılkaya, A. Ozkahraman· The European Research Journa...· 0 citations
Cancer patterns in the Kurdistan Region of Iraq changed substantially during the 12-year study period, with increasing proportions of colorectal and several other malignancies alongside an older age at diagnosis, likely reflect a combination of demographic changes, evolving lifestyle-related risk factors, and improveme...
This population-based study represents the largest Australian cohort of primary colorectal lymphoma reported to date and shows that PCL predominantly affects older males and is most commonly treated with chemotherapy-based regimens, which are associated with favourable survival.
Yaying Eileen Xu, Jennifer Liang, D. Clark· ANZ journal of surgery· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.